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Abstract
Background: Membrane proteins are the targets of 50% of drugs, although they only represent 1% of total cellular proteins.
The first major bottleneck on the route to their functional and structural characterisation is their overexpression; and simply
choosing the right system can involve many months of trial and error. This work is intended as a guide to where to start
when faced with heterologous expression of a membrane protein.
Methodology/Principal Findings: The expression of 20 membrane proteins, both peripheral and integral, in three
prokaryotic (E. coli, L. lactis, R. sphaeroides) and three eukaryotic (A. thaliana, N. benthamiana, Sf9 insect cells) hosts was
tested. The proteins tested were of various origins (bacteria, plants and mammals), functions (transporters, receptors,
enzymes) and topologies (between 0 and 13 transmembrane segments). The Gateway system was used to clone all 20
genes into appropriate vectors for the hosts to be tested. Culture conditions were optimised for each host, and specific
strategies were tested, such as the use of Mistic fusions in E. coli. 17 of the 20 proteins were produced at adequate yields for
functional and, in some cases, structural studies. We have formulated general recommendations to assist with choosing an
appropriate system based on our observations of protein behaviour in the different hosts.
Conclusions/Significance: Most of the methods presented here can be quite easily implemented in other laboratories. The
results highlight certain factors that should be considered when selecting an expression host. The decision aide provided
should help both newcomers and old-hands to select the best system for their favourite membrane protein.
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Introduction
Membrane proteins (MPs) perform a wide range of essential
biological functions and represent the largest class of protein drug
targets (for reviews, see [1–3]). Approximately 25% of all genes in
both prokaryotes and eukaryotes code for MPs [4] and in humans
15% of these are G protein-coupled receptors (GPCRs) [2].
However, the vast majority of MPs still have no assigned function
and only a little over 300 unique high-resolution 3D structures
have been obtained for transmembrane proteins so far. Most of
these structures are for bacterial and archaeal proteins, with only
very few from eukaryotic systems [1,2,5] (http://blanco.biomol.
uci.edu/mpstruc). This does not reflect the efforts deployed for the
study of MPs in laboratories worldwide, but is an indication of the
technical challenges posed by the hydrophobic nature, generally
low natural abundance and intrinsic instability of these proteins.
Obtaining sufficient amounts of MPs for functional and structural
studies is the first major bottleneck in their study [6–12]; and when
expressed in heterologous systems, the proteins are frequently i)
toxic for the host, ii) expressed at a very low level in a spatially-
delimited membranous environment and iii) mis- or unfolded (and
thus inactive) [13]. Protein overexpression involves three elements:
a gene, a vector and an expression host. The appropriate
combination of these elements maximises the amount and quality
of protein produced. However, since proteins are very diverse in
structure and physico-chemical properties, it is impossible to
predict whether a protein of interest will express well, be easy to
purify, be active or crystallise in any given experimental setup [14].
Consequently, it is often necessary to test various constructions in
diverse expression hosts. Traditional cloning methods with REaL
(Restriction Enzyme and Ligase) steps to generate multiple
expression plasmids (and constructs) are both labour-intensive
and time-consuming. This makes them incompatible with a
massively parallel strategy of expression screening. However, over
the past few years, several recombinatorial cloning systems have
been developed to allow rapid cloning of hundreds of genes and
constructs simultaneously [14–17]. Among these, the Gateway
technology [18], Creator [19] and the fragment exchange (FX)
cloning [20] present the advantage of enabling subcloning of an
open reading frame (ORF) into multiple expression vectors. Even
if often adding extra-sequences to the proteins, Gateway is the
most widely used and this technique has already been successfully
exploited for high-throughput cloning of MPs [21], and several
libraries from various ORFeome projects have been constructed
using Gateway vectors [22–27]. Gateway technology uses
bacteriophage lambda Int/Xis/IHF recombination at att sites to
transfer ORFs into vectors [28]. This divides the cloning
procedure into three steps, as illustrated in Figure S1. In addition,
most of the expression vectors available can be made Gateway-
compatible by inserting an adapter cassette containing Gateway-
specific recombination sites.
Once the expression vectors are obtained, production of the
target proteins can be tested in different prokaryotic and
eukaryotic expression systems suitable for overexpression of MPs
(for reviews, see [12,15,29–34]). However, each of these systems
has pros and cons, and the choice of the appropriate expression
system often remains empirical, particularly with regard to the
levels of functional protein expression. In the following para-
graphs, we will briefly present the host systems tested in this study.
Escherichia coli
E. coli is by far the most widely used expression host for the
production of recombinant proteins. Its short generation time, low
cost and ease of use, as well as its extensive characterisation make
it an ideal candidate (for a review see [35]). However, E. coli
presents some disadvantages for protein overexpression. In
particular, many MPs do not fold properly and form aggregates
that are then stored in inclusion bodies. Several recent
developments have improved the expression of recombinant
MPs in E. coli [36]. Strains like C41, C43 [13] or Lemo21 [37],
which are more tolerant to toxic MPs, or the introduction of tags
like GFP [38], MBP, GST, NusA [30] or Mistic [39] can facilitate
and improve MP production. Mistic is a 13 kDa protein from
Bacillus subtilis, which, when produced in E. coli, spontaneously
associates with the inner membrane, without requiring recognition
by the Sec translocon machinery. Due to this spontaneous
association with the membrane, Mistic has been successfully used
as an N-terminal fusion tag to target and facilitate membrane
insertion of various cargo MPs in E. coli [39–45].
Lactococcus lactis
L. lactis, like other food-grade lactic acid bacteria, is a non-
pathogenic, non-invasive Gram-positive bacterium. These prop-
erties have made it a popular candidate for the oral administration
of mucosal vaccines (for recent reviews, see [46–50]). Thanks to
the development of a wide range of genetic engineering tools (for a
review see [51]), it is also widely used today for large-scale
production of heterologous proteins [29,30,46].
Recombinant protein production in L. lactis can be performed
using the Nisin-Inducible Controlled gene Expression (NICE)
system, in which nisin, an antimicrobial peptide, is used to
promote the expression of genes positioned in plasmids under the
control of the nisin-inducible promoter PnisA (see review [47]). This
system has been used to produce various eukaryotic MPs in L. lactis
[9,30,46,52–54]. GFP has also been used to monitor the state of
protein folding, in order to select evolved hosts with enhanced
functional expression of membrane proteins [55]. One of the
major advantages of L. lactis over E. coli is that inclusion bodies
have (so far) not been observed in this host [9]. In addition, it only
has a single cell membrane, making the direct use of ligands or
inhibitors for activity studies of membrane proteins in whole cells
possible. Until recently, expression screening of multiple constructs
in L. lactis was limited by the absence of efficient cloning
procedures, but recent developments based on ligation-indepen-
dent cloning (LIC) and Gateway technology have made it possible
to clone many genes in parallel [54,56,57].
Rhodobacter sphaeroides
R. sphaeroides is a purple non-sulphur photosynthetic bacterium.
The pigment-protein complexes of the photosynthetic apparatus
(reaction centres, light-harvesting complexes) are located in
invaginations of the cytoplasmic membrane, known as chromato-
phores. In response to light and/or lowered oxygen tension, the
bacteria synthesises large amounts of photosystems [58], and the
increasing number of chromatophores causes the membrane
surface area to increase vastly. This increase in the intracytoplas-
mic membrane surface could be very useful for the production of
MPs. Indeed, one of the major limitations for MP production in
many hosts is the limited membranous space available. In R.
sphaeroides, foreign MP synthesis can be coordinated with the
synthesis of new membranes to accommodate them. This property
has already been used to produce heterologous MPs for structural
studies [59].
Arabidopsis thaliana
A small flowering plant with a relatively short life cycle of two
months, A. thaliana is a popular model organism in plant biology
and genetics. Its small genome was fully sequenced in 2000 [60]. A.
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thaliana is not regarded as a classical overexpression system since
most plant MPs are overexpressed in plants to test their in vivo
function rather than to obtain sufficient amounts for crystallisation
trials. A. thaliana can be both stably transformed (by floral dipping
[61]) and transiently transformed (by agro-infiltration with
Agrobacterium tumefaciens [62]). When overexpressing MPs in this
organism using stable transformants, the main limitation is the
long culture cycle, lasting two months between generations of
plant seeds, as compared to only 30 to 50 min for bacteria.
Nicotiana benthamiana
Widely used as an experimental host in plant virology, N.
benthamiana can be efficiently genetically transformed and regen-
erated. It is therefore amenable to transient protein expression
[63]. This host is rapidly gaining popularity in plant biology,
particularly in studies requiring protein localisation, interaction, or
plant-based systems for protein expression and purification.
Transient Agrobacterium-mediated transformation of N. benthamiana
using leaf disks has provided the plant community with a valuable
tool to rapidly evaluate transgenes in higher plants [64] and to
produce gram quantities of recombinant proteins [65]. This
protocol has a number of significant advantages: readily available
explant material, high efficiency, and a relatively quick turnaround
time.
Insect cells and the baculovirus system
The baculovirus system is widely used for eukaryotic protein
expression in insect cells [66,67] as a compromise between
bacterial expression and expression in mammalian (stably or
transiently transfected) cells. Indeed, although more expensive and
time-consuming than expression in E. coli, this system is more
compatible with eukaryotic proteins because of similar codon
usage rules, providing better expression levels and fewer truncated
proteins than in bacteria. In addition, this system allows for post-
translational modifications. Some of the post-translational modi-
fications produced are not identical to those found in mammals
(glycosylations for example), but they are nevertheless closer than
those produced by bacteria, or even yeast [68]. Insect cells are
easier and cheaper to handle than adherent cells like HEK 293,
COS or CHO cells, especially for scale-up. Thus, these cells used
with the baculovirus system have a real potential for the
heterologous production of MPs. Briefly, the baculovirus system
relies on the infection of insect cell lines (usually Sf9, Sf21 or High
FiveH) by recombinant viruses encoding the gene(s) of interest.
Many improvements to recombinant baculovirus generation have
been implemented over the last twenty years [69], including the
Bac-to-Bac system (Invitrogen), which uses site-specific transposi-
tion in E. coli rather than homologous recombination in insect
cells. Gene expression is generally driven by the polyhedrin or p10
late promoter. A similar system (BacMam, Invitrogen) has recently
been developed to allow baculovirus-based expression in mam-
malian cells.
Rationale for the current study
Several studies comparing different expression systems for MP
production have already been performed. However, these studies
focused either on the expression of a given protein [7] or a family
of proteins such as GPCRs [12,70]. Other laboratories have tried
to express MPs only in E. coli [21,71,72] or L. lactis [73]. Moreover,
except for GPCRs [12,70], the expression of eukaryotic MPs has
only been compared in either prokaryotic [74] or eukaryotic [75]
hosts. To our knowledge, our study is the first to compare the
overexpression of 20 prokaryotic and eukaryotic MPs in both
prokaryotic (E. coli, L. lactis and R. sphaeroides) and eukaryotic (A.
thaliana, N. benthamiana and Sf9 insect cells) expression hosts. This
study is also original as we evaluate commonly used hosts such as
E. coli and, to a lesser extent, insect cells together with more
unusual systems, to test their ability to be used as alternative
expression hosts. As overexpression of membrane proteins is a
challenge in itself, we focused our attention on the production step,
and on the yields obtained in the various expression hosts tested.
However, in extensions of the present study, we were able to show
that some of the proteins produced here could be purified to
homogeneity and were active [54,76,77]. The present article
highlights several successful strategies for the heterologous
expression of the MPs studied (from different protein families
and with large variations in topology and origin) and discusses
possible further improvements to MP expression. But, most
importantly, it provides a first-stop analysis of the pitfalls and
advantages of the various systems tested depending on the nature
of the MP to be expressed. This should be of use to all who are
about to venture into this exciting, and sometimes frustrating, field
of biology.
Materials and Methods
Cloning using the Gateway technology
The cloning steps were performed using Gateway technology
(Invitrogen) according to the manufacturer’s instructions, but by
reducing the volume and quantities of all components (clonase
enzyme, buffer, PCR products and vectors) to 1/8th during the
recombination steps (BP and LR reactions), to yield a total
reaction volume of 2.5 ml that was entirely used for transforma-
tion. Briefly, the ORFs coding for the selected proteins (Table 1)
were amplified by PCR and flanked with attB specific recombi-
nation sites. All the genes were also extended with a sequence
coding for a Strep-tag II at either the N- or C- terminal end of the
constructs. The PCR products were purified and either recom-
bined with a pDONR221 donor vector (Invitrogen) through a BP
reaction or cloned into pENTR-D-TOPO vectors through
directional topoisomerase-mediated cloning (TOPO, Invitrogen)
to yield the ‘‘entry’’ clones. The entry clones were first sequenced
to check the integrity of the cloned genes and then used in an LR
Gateway reaction together with various destination vectors to yield
expression vectors specific to each expression system tested in this
study (Table 2).
E. coli expression vectors. To test the expression of the
proteins in E. coli, the genes were transferred into the destination
vectors pDEST17 (Invitrogen) and pDEST-Mistic. pDEST-Mistic
was obtained by modifying the vector pDEST17 by introducing
the sequence coding for Mistic (Accession nu AAX20121) between
the coding sequences of the hexa-histidine tag and the attB1 site
through RF cloning as described by van den Ent and Lo¨we [78].
L. lactis expression vector. The vector pNZ8148
containing the NICE system was used for expression in L. lactis.
This vector wasn’t converted into a Gateway destination vector,
because it is known to be very unstable in E. coli and because of the
lack of Lactococcus strains able to propagate Gateway vectors.
Therefore, the cDNAs were first transferred into the vector pBS-
RfA using the Gateway system and subsequently cloned into
pNZ8148 through digestion of pBS-RfA vectors by EcoRV and
re-ligation (for details, see [54]). For some proteins (MraY,
AtHMA3, AtHMA4 and a2d subunit), with one or several
EcoRV restriction sites within the ORF sequence, a partial
restriction of the donor plasmids with this restriction enzyme led to
a correct excision of the cassette containing the entire gene.
Afterwards, Lactococcus strain NZ9000 was transformed with the
recombinant plasmids as previously described [79] and the
Heterologous Expression of Membrane Proteins
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presence of the insert in the right orientation was confirmed using
restriction analyses, PCR amplification and subsequent sequencing
[80].
R. sphaeroides expression vector. For expression in R.
sphaeroides, the broad-host-range plasmid pBBR1MCS-2 [81] was
modified to convert it into a Gateway destination vector and to
change the antibiotic resistance. An omega cartridge encoding
resistance to streptomycin and spectinomycin was obtained
through BamHI digestion of pHP45V plasmid [82] and cloned
into pBBR1MCS-2 previously digested with BglII. The aph gene
encoding resistance to kanamycin was inactivated by the excision
of a 400 bp NcoI fragment. To enhance protein expression, the
strong promoter and the RBS of the puc operon (encoding light
harvesting complexes II) were cloned into the resulting plasmid,
pBBR1MCSV. This was done by amplifying R. sphaeroides genomic
DNA by PCR, using the primers 59-AAGGTACCCTGC-
Table 1. List of selected target proteins.
Acc n6 UNIPROT Protein name Function Organism Size (kDa) Topologya Reference
Q6NCP8 P450 Cytochrome -
mono-oxygenase
R. palustris 49.7 Peripheral [87]
O88116 NapC Cytochrome –
electron transfer
R. sphaeroides 24.2 1 TM [110]
Q8DMY2 MreC Peptidoglycan
synthesis
S. pneumoniae 29.7 1 TM [111]
Q8DQH3 FtsX Cell division S. pneumoniae 34.2 4 TM [112]
Q8DR69 MraY Peptidoglycan
synthesis
S. pneumoniae 36.0 10 TM [113]
A5X8Y8 LPR1 Multi-copper
oxydase
A. thaliana 60.5 Peripheral [114]
Q9SV68 ceQORH Quinone oxydoreductase –
electron transfer
A. thaliana 33.1 Peripheral [100,101]
Q8GYE0 PHF Phosphate transport regulation A. thaliana 42.4 1 TM [115]
Q9M3H5 AtHMA1 Heavy metal transporter A. thaliana 80.1 6 TM [116]
P31167 AAC Mitochondria ADP/ATP transporter A. thaliana 33.2 6 TM [117]
Q66474 AtHMA4 Heavy metal transporter A. thaliana 126.7 8 TM [118]
Q9SZW5 AtHMA3 Heavy metal transporter A. thaliana 81.4 8 TM [119]
Q96303 PHT1;4 Phosphate transporter A. thaliana 57.2 12 TM [120]
Q39002 NTT1 Chloroplast ADP/ATP transporter A. thaliana 57.5 12 TM [121]
P54290 a2d subunit Calcium channel regulation R. norvegicus 122.2 1 TM [122]
P04633 UCP1 Uncoupling protein R. norvegicus 31.3 6 TM [123]
Q07817 Bcl-xL Apoptosis regulation H. sapiens 24.7 1 TM [124,125]
P61073 CXCR4 GPCR H. sapiens 37.9 7 TM [126]
P51681 CCR5 GPCR H. sapiens 38.7 7 TM [127,128]
Q92911 NIS Iodide transporter H. sapiens 67.6 13 TM [129]
aFor some of the proteins, the topology is still unclear and the number of TMs given here corresponds to the predicted topology.
doi:10.1371/journal.pone.0029191.t001
Table 2. Protein constructs obtained from the different expression vectors.
Expression host Expression vector Expressed protein construct*
E. coli pDEST17 MSYY(H6)LE-attB1-MP-Strep
E. coli pDEST-Mistic MSYY(H6)LE-Mistic-attB1-MP-Strep
L. lactis pNZ8148 MI-attB1-MP-Strep
R. sphaeroides pDEST-E VDI-attB1-MP-Strep
A. thaliana/N. benthamiana pAlligator-3 M-MP-Strep
Insect cells pDEST8 M-MP-Strep
Sequences are presented using one-letter code for amino acids. attB1: amino acid sequence encoded by the attB1 cloning site corresponding to TSLYKKAGS when the
entry clone was prepared though BP cloning and TSLYKKAGSAAAPFT when the entry clone was prepared through TOPO recombination (NapC, P450, LPR1, PHF, PHT1;4,
ceQOHR, AtHMA1, Bcl-xL). MP: amino acid sequence of the different membrane proteins. Mistic: amino acid sequence of the fusion tag Mistic. Strep: amino acid
sequence of the Strep-tag II fusion tag corresponding to WSHPQFEK.
*The Strep-tag II was fused to the C-terminus of most proteins, except for proteins AtHMA3, AtHMA4 and Bcl-xL for which the Strep-tag II was located at the N-terminus
of the MP sequence.
doi:10.1371/journal.pone.0029191.t002
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AGGCCCACGCCCTGAA-39 and 59-AAGATATCCACTGT-
GTCGTCTCCCAACT-39. The 0.7 kbp PCR product was then
digested with KpnI and EcoRV and cloned into pBBR1MCSV.
Finally, the resulting plasmid was linearised with EcoRV and a
Reading Frame Cassette A (RfA) (Invitrogen) was introduced to
convert it into a Gateway destination vector.
A. thaliana and N. benthamiana expression vector. The
expression vector used for plant transformation was the
pAlligator3 vector [83] containing the spectinomycin resistance
marker gene and the CaMV 35S promoter (Cauliflower Mosaic
Virus). This vector also includes a gene coding for GFP, driven by
the At2S3 seed-specific promoter and used as a selectable marker
for transformed seeds, as well as the Gateway cloning cassette [83].
A. tumefaciens strain (C58) was transformed with the different
expression vectors as previously described [84] and the presence of
recombinant vectors was verified by plasmid isolation and
restriction analysis.
Insect cell expression vectors and bacmids. The entry
clones were recombined (LR reaction) with the commercial
destination vector pDEST8 (Invitrogen) to generate the expression
plasmids, which were checked by restriction digest. According to the
Invitrogen manual, the only requirement needed to use pDEST8
when designing the ‘‘Entry’’ clone, is the insertion of an ATG start
codon for proper initiation of translation. These plasmids were
subsequently transformed into DH10BacTM (Invitrogen) for
transposition with the parent bacmid. After the blue/white
screening of positive recombinants (LacZa complementation
system on the bacmid), the various recombinant bacmids thus
obtained were further checked by PCR for the presence of the genes
of interest.
Protein expression in the different systems
E. coli based expression. Expression vectors were used to
transform C43(DE3) (Avidis) and BL21-AI (Invitrogen) competent
cells. Expression tests were performed in 24-Deep well plates
containing 3 mL of TB medium (100 mg/mL Ampicillin). The
cultures were inoculated with overnight pre-cultures at a 1/40th
dilution and grown for 2 h at 37uC under agitation (250 rpm).
Protein expression was then induced by addition of either 1 mM
IPTG for C43 cells or 0.005% (w/v) arabinose for BL21-AI cells
and the cultures were incubated for another 16 h at 20uC under
agitation (250 rpm). The cells were harvested by centrifugation
(3200 g, 10 min, 4uC) and the cell pellet resuspended in 250 mL of
PBS buffer containing lysozyme (Novagen), benzonase (Novagen)
and Complete antiprotease cocktail (Roche). Cells were disrupted
using a water bath sonicator and debris were removed by
centrifugation (20,000 g, 20 min, 4uC). Membranes present in
the supernatant were separated by ultracentrifugation (100,000 g,
1 h, 4uC). Finally, the membrane pellet was resuspended in
250 mL PBS buffer and 10 mL aliquots were analysed on gradient
4–20% SDS-PAGE gels (Bio-Rad) and by western blots (WB).
Total MP content was determined using the BCA protein assay
(Pierce).
L. lactis based expression. Expression tests were performed
in 1 L-cultures and crude bacterial membranes were purified as
previously described [80]. Briefly, transformed NZ9000 Lactococcus
cells were grown in 1L of M17 medium (Difco) supplemented with
1% (w/v) glucose and 10 mg/mL chloramphenicol. Cultures were
inoculated with 25 mL of overnight pre-cultures and grown at
30uC under gentle shaking (90 rpm). Protein expression was
induced when the OD600 reached 0.8, with a 0.005 volume of the
nisin A-containing supernatant obtained from a culture of the L.
lactis NZ97000 nisin-producing strain (NIZO). After induction the
cells were grown for an additional 4 h at 30uC, under gentle
shaking (90 rpm). The cells were then harvested (5000 g, 15 min,
4uC) and resuspended in 40 mL of Tris buffer (50 mM Tris-HCl
pH 8.0, 100 mM NaCl). Bacteria were lysed using a cell disruptor
(One shot, Constant Systems) by 2-fold passages at 35,000 p.s.i.
( = 2.3 kbars) and the lysates clarified by centrifugation (10,000 g,
10 min, 4uC). The supernatant containing the membranes was
then ultracentrifuged (150,000 g, 1 h, 4uC) and the membranes
were resuspended in 2 mL of PBS-Glycerol (10% (v/v)). Total MP
content was measured using the Bio-Rad protein assay (Bio-Rad)
and 20 mg of proteins were analysed on 10% SDS-PAGE and by
western blots. Bacteria containing the empty pNZ8148 vector
were systematically grown in parallel and used as negative control
to validate the nature of the detected signals.
R. sphaeroides based expression. The expression vectors
were mobilised from E. coli to R. sphaeroides f. sp denitrificans IL106
by conjugation. Cells were grown for 24 h at 30uC in Hutner
modified medium [85] under aerobic conditions (100 mL medium
in 250-mL erlenmeyer flasks, 150 rpm) or phototrophic conditions
(180 mmol of photons.m22. s21) with 25 mg/mL kanamycin. Cells
were harvested (7000 g, 10 min, 4uC) and resuspended in 8 mL of
Tris buffer (50 mM Tris-HCl pH 8.0). The bacteria were lysed
using a cell disruptor (One shot, Constant Systems) and the lysates
clarified by centrifugation (7000 g, 10 min, 4uC). The supernatant
containing the membranes was then ultracentrifuged (200,000 g,
1 h, 4uC) and the membranes were resuspended in 1 mL of Tris
buffer. The protein content was measured with the BC assay
(Interchim) in 2% SDS, and 25 mg of proteins were analysed by
10% SDS-PAGE and by western blots.
A. thaliana based expression. Plants were grown in culture
chambers at 23uC (8-h light cycle) with a light intensity of
150 mmol?m22?s21 in standard conditions. Wild-type Arabidopsis
plants ecotype Wassilevskija background were transformed by
dipping the floral buds of 4–5-weeks-old plants into an A.
tumefaciens (C58 strain) solution containing a surfactant (Silwett
L-77) according to Clough and Bent [86]. Primary transformant
seeds were selected on the basis of GFP fluorescence [83] and
germinated in Petri dishes containing solidified medium
(Murashige and Skoog, 0.5% (w/v) sucrose, and 0.8% (w/v)
agarose) for 2 weeks before transfer to soil. After 3–4 weeks, total
MPs were extracted from 1–2 leaves. Finally, membrane proteins
were diluted in 200 mL of Tris buffer (50 mM Tris-HCl pH 6.8,
1% Triton X-100) and 25 mg aliquots were analysed on 12% SDS-
PAGE and by western blots.
N. benthamiana based expression. Plants were grown in
culture chambers at 20uC (14 h light cycle) with a light intensity of
60–120 mmol?m22?s21 in standard conditions. Three or four
week-old wild-type Nicotiana benthamiana plants were infiltrated with
a solution of A. tumefaciens (C58 strain) according to Witte et al.
[64]. Total MPs were extracted from 2 leaf discs harvested after 4
days [59]. Finally, membrane proteins were resuspended in 70 mL
of buffer (100 mM Tris-HCl pH 8, 5 mM EDTA, 150 mM NaCl,
5 mM DTT, anti protease inhibitors, 1% Triton X-100) and
10 mL aliquots were analysed on 10% SDS-PAGE and by western
blots.
Sf9 insect cells based expression. The bacmids were
amplified in DH10Bac and purified using the S.N.A.P.TM
MidiPrep Kit (Invitrogen). Sf9 cells were transfected with
cellfectin according to Invitrogen’s protocol (Bac to Bac
baculovirus expression system) and incubated for 72 h to get the
P1 viral stock. This P1 viral stock was then amplified by infecting
Sf9 cells and the P2 viral stock thus obtained was subsequently
used for expression experiments. The precise titers of these viral
stocks have not been determined and after preliminary
experiments to determine the best conditions for protein
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29191
expression, 10% of viral inoculum was used for all the
experiments. After infection, cells (approximately 106 per well)
were incubated at 27uC for 48 h, and centrifuged for 5 minutes at
1000 g. For analyses on whole cell extracts, the cells were then
washed in PBS and resuspended in 300 mL of 10 mM Tris-HCl
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
SDS plus protease inhibitors and kept on ice for 20 min. The
lysate was centrifuged at 16,000 g for 15 min to remove the non-
solubilised material. For analyses on membrane fractions, the cell
pellet was suspended in 1 mL of cold 20 mM Tris pH 7.5,
250 mM sucrose, plus anti-proteases (Complete, Roche) buffer.
After breaking the cells with a Dounce homogeniser (10–15
passages on ice), the lysate was centrifuged at 1000 g for 10 min.
The supernatant was transferred and centrifuged at 10,000 g for
10 min. At last, from this supernatant, membranes were
concentrated as a pellet at 100,000 g for 1 h. All steps were
performed at 4uC or on ice. MPs were diluted in 300 mL of
25 mM Tris, pH 7.5, 100 mM mannitol plus anti-proteases
(Complete, Roche). Total MPs were determined using the BCA
protein assay (Pierce). For western blot analysis 20 mg of proteins
were loaded onto a NOVEX NuPAGE 4–12% Bis-Tris gel
(Invitrogen) with MES/SDS running buffer. Non-infected cells
were used as a control.
Western blot analysis
The membrane fraction extracted from cells from each
expression system was analysed by western blotting using the
Strep-tag II sequence as the antigenic epitope, unless specified
otherwise. Western blots were performed using the Strep-tag HRP
Detection Kit (IBA) according to the manufacturer’s instructions,
unless otherwise stated. The amounts of target proteins present in
isolated membrane samples were quantified by densitometry with
background correction and comparison to known amounts of a
control Strep-tagged protein loaded on the same blot. For both
plant expression systems we followed the protocol described by
Witte et al. [64], with some modifications for Arabidopsis by adding
a blocking step with the biotin blocking buffer because of the
presence of several biotinylated proteins in Arabidopsis crude
membrane extracts. For L. lactis, two different methods were
applied depending on the expression level of the protein as
previously described [54]. Total membrane protein (TMP)
concentrations in isolated membrane samples were also deter-
mined using conventional colorimetric methods as stated above.
Results
Generation of expression plasmids and cell lines
Our aim was to test the overexpression of 20 MPs (Table 1) in
six host organisms, this required engineering 120 expression
vectors. Gateway technology was used to optimise and streamline
cloning, providing a success-rate over 99% for plasmid generation.
The only expression plasmid not produced at all was the L. lactis
expression vector for the a2d subunit, which was lost in the cloning
step after the Gateway step. This was probably due to the large
(.4 kbp) size of the cDNA, or to the presence of several EcoRV
restriction sites within the gene sequence. In the baculovirus
system, all 20 pDEST8 recombinant plasmids were obtained.
However, the corresponding bacmids could not be produced for
P450 and NIS. In all other organisms, all 20 cell lines were
successfully produced.
Expression results
The proteins in this study belong to diverse protein families, are
of both prokaryotic and eukaryotic origin, and their topology
ranges from peripheral MPs to integral MPs (IMPs) containing
between one and thirteen predicted transmembrane (TM) regions
(Table 1). To evaluate the efficiency of the different expression
systems, after protein expression, the membranes were isolated as
described in Material and Methods. The amount of target protein
in the membranes was determined by western-blot, using the Strep-
tag II sequence (if not otherwise stated) to reveal the presence of
target protein on the membrane (See Figure 1 (A) to (G) and
Table 3). Expression levels are generally given in mg/L of culture
for bacteria and Sf9 cells. However, because we also used plant
systems, we also considered the production levels as a percentage,
target MP within the total pool of membrane proteins (TMP)
(Table 3). This made it possible to compare all the different
expression systems used here.
Expression in E coli. Prior to the screen of the 20 proteins,
several expression conditions (concentration of inducing agent and
temperature) were tested for the production of a few proteins in
BL21-AI. A concentration of 0.005% arabinose and an overnight
induction at 20uC gave the best results. For C43 strain, a
concentration of 1 mM IPTG was retained. These conditions were
then applied in the expression screening that was performed in
triplicate for all proteins in both strains. No significant differences
were observed between the strains in terms of expression levels,
therefore the results were averaged in Table 3. Two plasmids were
used to transform E. coli: pDEST17 yielded a construct in which
the amino acids encoded by the attB1 recombination site formed a
linker between an N-terminal His-tag and the proteins (Table 2);
whereas with pDEST-Mistic, Mistic was located between the N-
terminal His-tag and the attB1sequence, followed by the target
protein (Table 2). A representative western blot of proteins
produced in E. coli is shown in Figure 1A. Detection of western
blots using Strep-Tactin HRP conjugates had a useful side-effect in
E. coli, where a soluble endogenous biotinylated protein, biotin
carboxyl carrier protein (BCCP; 22.5 kDa), was detected. This
protein should be absent from the membrane fraction and was
therefore used to control the purity of this fraction (Figure 2).
Detectable amounts of full-length protein were obtained for 15
out of the 20 MPs (the three peripheral proteins and 12 IMPs) in
E. coli with or without fusion to Mistic. For the other five proteins,
either no signal was detected, or the MW was too far removed
from the expected value (e.g. for NIS, a signal was observed at one
third the expected MW). Bands of this type could be the result of
proteolytic degradation, internal initiation or premature termina-
tion. Since the proteins produced in E. coli had both a His-tag and
the Strep-tag II sequence, western blots could also be probed using
anti-His antibodies. This was done for a few proteins that were not
detected with the Strep-tag, to check whether the lack of signal was
due to the absence of the protein, or to a tag detection problem.
For FtsX, a signal was indeed obtained with anti-His, indicating
that, for this protein there was some problem with the Strep-tag II.
This type of problem may also have occurred for some proteins in
the other expression systems (see below).
Mistic fusion significantly increased the yields of the 12 IMPs
produced in E. coli. In contrast, it had a negative effect when fused
to peripheral proteins, drastically reducing the amount of target
protein associated with the isolated membranes in all three cases.
This should therefore be taken into account when selecting a
vector for protein expression.
Functional studies, detailed elsewhere [54,76,77], showed
several of these proteins to be active and readily purified.
Expression in L. lactis. Before screening for expression of
all proteins in L. lactis, culture conditions were optimised
(temperature, induction time and concentration of nisin) for two
representative proteins, one peripheral (ceQORH) and one
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Figure 1. Examples of western blot analysis of cell extracts from the different hosts. (A)Western blot analysis of membrane extracts
of E. coli. In this case, the native and Mistic-NTT1 fusion. C: Strep-tag II control protein loaded at 25, 50, 75 or 100 ng. AI: proteins produced in BL21-
AI. 43: proteins produced in C43. MW: molecular weight standard. Arrows point out the different target proteins. *: Partly proteolysed NTT1 protein.
The membrane was probed with the Strep-Tactin HRP conjugate (IBA). (B)Western Blot analysis of membrane extracts of L. lactis. C: Strep-tag II
control protein loaded at 2000, 200 or 20 ng as written above. MW: molecular weight standard. Arrows point out the different target proteins. The
membrane was probed with the Strep-Tactin HRP conjugate (IBA). (C) Western blot analysis of membrane extracts of R. sphaeroides. C: Strep-
tag II control protein loaded at 30 ng as written above. MW: molecular weight standard. Arrows point out the different target proteins. The
membrane was probed with the Strep-Tactin HRP conjugate (IBA). (D) Western blot analysis of membrane extracts of A. thaliana. In this case,
the expression of the protein AAC was tested in 5 different transformed plants. The membrane fraction was isolated and the extracts corresponding
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intrinsic MP (AtHMA1). The nisin used for induction was
produced in-house as described in Material and Methods, and
the same batch was used for all the tests performed in this study.
Optimal production of both proteins was achieved by adding
0.005 volume nisin A-containing NZ9700 medium supernatant to
a culture at OD600<0.8. Production levels were two- to three-fold
higher when the cells were grown at 30uC for 4 h after induction,
rather than overnight at 20uC (data not shown). These culture and
induction conditions were then applied to test the expression of all
20 proteins. Thirteen of the 20 proteins tested were successfully
produced. The quantities of MPs obtained were about 1/10th
those provided by E. coli (Table 3; for a representative western
blot, see Figure 1B). However, the plant protein ceQORH was
produced at 9 mg/L, which corresponded to 30% of the TMPs in
these cells. This is comparable to the levels obtained with
prokaryotic MPs. As in E. coli, some of the proteins that could
not be identified through the Strep-tag II, could be detected using
other antigenic epitopes. For example, AtHMA4, which contains
an internal poly-histidine sequence, could be detected using anti-
His antibodies, while AtHMA3 and Bcl-xL were detected using
protein-specific antibodies (Figure 3).
Further functional studies were performed on some of the
proteins expressed in L. lactis, these are detailed elsewhere [54].
The specific activity of the protein ceQORH was significantly
improved in this host compared to E. coli.
Expression inR. sphaeroides. In R. sphaeroides, intracytoplasmic
membrane is synthesised in response to specific growth conditions. We
tested the expression of target proteins under both phototrophic
anaerobic conditions and semi-aerobic conditions. The different
conditions did not have a significant impact on results, and only four
proteins could be produced in this host (Table 3; for a representative
western blot, see Figure 1C). Cytochrome P450 was found to be
correctly folded and active, since it could fix CO [87]. However, we
were quite surprised by the limited (20%) success rate of membrane
protein expression using this system. Indeed, in other experiments,
large amount of soluble proteins were produced using either a pRK415
[88] or a pBBR1MCS-2 derivative with the puc promoter. This vector
also allows expression of MP, since we were able to express cytochrome
to the different plants tested (lanes 1 to 5) were analysed. C: Strep-tag II control protein loaded at 50 ng as written above. MW: molecular weight
standard. The arrow points out the protein AAC. The membrane was probed with the Strep-Tactin HRP conjugate (IBA). (E) Western blot analysis
of membrane extracts of N. benthamiana leaf discs. C: Strep-tag II control protein loaded at 1, 2, 5, 10 or 20 ng as written above. MW: molecular
weight marker. Arrows point out the different target proteins. The membrane was probed with the Strep-Tactin HRP conjugate (IBA). (F) Western
blot analysis of whole cell extracts of Sf9 insect cells. MW: molecular weight standard. Arrows point out the different target proteins. The
membrane was probed with the anti-Strep-Tag II (IBA) and a goat anti mouse–HRP secondary antibody. (G) Western blot analysis of membrane
extracts of Sf9 insect cells. This figure is an example of a western-blot for the quantification of target proteins in Sf9 cells membrane vesicles. Here,
membrane vesicles of Sf9 cells overproducing either no protein (2), ceQORH, AtHMA1 or Bcl-xL were deposited. C: Strep-tag II control protein loaded
at 150, 100, 50, 10 ng as written above. Arrows point out the different target proteins. The membrane was probed with the Anti-Strep-Tag II (IBA) and
a goat anti mouse–HRP secondary antibody.
doi:10.1371/journal.pone.0029191.g001
Table 3. Protein yields obtained in the different expression hosts.
Protein name E. coli (His) E. coli (Mistic) L. lactis R. sphaeroides Insect cells A. thaliana N. benthamiana
P450 ¤¤¤¤ (5–10%) – ¤¤ (1–3%) ¤¤¤¤ (1–3%) n.c. n.a. (,0.1%) n.a. (,0.1%)
NapC ¤¤¤ (3–5%) ¤¤¤¤ (15–20%) ¤¤ (0.5–1%) – ¤ (,0.1%) n.a. (0.1–0.5%) n.a. (,0.1%)
MreC ¤¤¤¤ (10–15%) ¤¤¤¤¤ (15–20%) ¤¤¤ (0.5–1%) – ¤ (,0.1%) n.a. (,0.1%) n.a. (,0.1%)
FtsX ¤¤¤ (3–5%) ¤¤¤¤ (5–10%) – – – – –
MraY – – – – – – –
LPR1 ¤¤¤¤ (1–3%) – ¤ (0.1–0.5%) – – – –
ceQORH ¤¤¤¤¤¤ (15–20%) ¤¤¤¤ (10–15%) ¤¤¤¤¤¤ (30%) ¤ (,0.1%) ¤¤ (0.5–1%) n.a. (0.1–0.5%) n.a. (0.5–1%)
PHF ¤¤¤¤¤ (5–10%) ¤¤¤¤¤ (10–15%) ¤¤¤¤ (1–3%) – ¤¤ (0.1–0.5%) – n.a. (0.1–0.5%)
AtHMA1 – ¤¤¤ (3–5%) ¤¤ (1–3%) – ¤ (,0.1%) n.a. (,0.1%) –
AAC ¤¤¤ (1–3%) ¤¤¤¤ (3–5%) – – ¤¤ (0.1–0.5%) n.a. (0.1–0.5%) –
AtHMA4 – – ¤ (0.5–1%) – – – –
AtHMA3 – – ¤¤ (0.5–1%) – – n.a. (,0.1%) –
PHT1;4 ¤¤¤ (3–5%) ¤¤¤¤ (5–10%) – – – – –
NTT1 ¤¤¤¤ (3–5%) ¤¤¤¤¤ (5–10%) ¤¤ (0.1–0.5%) – – n.a. (,0.1%) –
a2d subunit – – n.c. – – – –
UCP1 ¤¤¤ (3–5%) ¤¤¤¤ (5–10%) – ¤¤ (0.1–0.5%) ¤¤ (0.1–0.5%) n.a. (,0.1%) n.a. (,0.1%)
Bcl-xL ¤¤¤ (1–3%) ¤¤¤¤ (3–5%) ¤¤ (0.5–1%) ¤ (,0.1%) ¤¤ (0.1–0.5%) n.a. (,0.1%) n.a. (,0.1%)
CXCR4 ¤¤¤ (1–3%) ¤¤¤¤ (3–5%) ¤ (,0.1%) – – – –
CCR5 ¤¤¤ (1–3%) ¤¤¤¤ (3–5%) ¤ (,0.1%) – – – –
NIS – – – – n.c. – –
For each protein, the yield obtained is expressed in mg of target protein/liter of cell culture (black squares) and as percentage of total membrane protein (% TMP)
(figures in brackets). –: protein not detected by western blot, ¤=protein produced at a yield below 0.1 mg/L culture, ¤¤= 0.1–0.5 mg/L, ¤¤¤= 0.5–1 mg/L,
¤¤¤¤= 1–4 mg/L, ¤¤¤¤¤= 4–7 mg/L and ¤¤¤¤¤¤ .7 mg/L. n.a. = not applicable, as the two plant systems are not cultured in liquid media. n.c. = not cloned.
doi:10.1371/journal.pone.0029191.t003
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bc1 and to complement a cytochrome bc1 null mutant (data not shown).
Even more surprising was the lack of production of homologous NapC,
the tetraheme electron donor of the periplasmic nitrate reductase,
NapAB. To test whether this was due to the use of the Gateway cloning
approach, we cloned the napC gene in the pBBR1MCS2 vector with
the puc promoter using traditional cloning methods (Restriction enzyme
and Ligase). This plasmid was able to restore the nitrate reductase
activity in a R. sphaeroides napC null mutant, thus demonstrating effective
expression of active NapC. This indicates that, with the Gateway
expression system, the additional amino acids encoded by the attB1
sequence (Table 2) may be a source of problems in this host.
Alternatively, as we did not perform functional studies with the
Gateway clones, the absence of protein detected by western blot could
simply be the result of problems with Strep-tag II detection, as
mentioned above for other proteins, rather than low expression or
absence of product in this system. Whatever the case, this host is not an
ideal candidate for Gateway-based protein expression of MPs in the
conditions used in this study.
Expression in A. thaliana. In A. thaliana, 50% of the
proteins tested were produced (Table 3, for a representative
western blot, see Figure 1D). Surprisingly, not all the proteins
originating from Arabidopsis were successfully expressed. This
may be due to a detection problem, as discussed above.
Alternatively, it may stem from silencing of the transgene by the
host cells. For example, all the plants carrying the LPR1 transgene
displayed a typical lpr1 mutant phenotype, indicating that the
endogenous LPR1 gene was also silenced (data not shown). The
ubiquitous presence of biotinylated proteins in A. thaliana made it
necessary to adapt conditions for the western blot analysis, such as
by the use of specific blocking buffer and/or avidin prior to
conjugate incubation, as described by Witte et al. [64]. As several
Arabidopsis proteins were tested in this study, in some cases we
checked whether the recombinant protein was correctly targeted
to its native location (membrane). For instance, AAC is an ADP/
ATP transporter located in the inner mitochondrial membrane.
Mitochondrial membranes were purified from the leaves of
transgenic Arabidopsis plants overexpressing AAC using two
different isolation procedures [89,90]. The presence of the
recombinant protein was assessed by western blot using the
Strep-Tactin HRP conjugate (Figure 4). While we found the
procedure described by Brugie`re et al. [89] to be more efficient, in
both cases the protein was enriched in the mitochondrial fraction
compared to crude cell membranes, demonstrating efficient
targeting of the recombinant protein to the organelle and
indicating that the Strep-tag II did not interfere with its insertion
into the membrane.
Figure 2. Isolation of the membrane fraction from E. coli cells. In
this case extracts of E. coli cells overexpressing either the Mistic fusion
of the protein NapC or the protein P450. cl stands for ‘‘cleared lysate’’
corresponding to the supernatant recovered after centrifugation, at
20,000 g, of the cell lysate. hs and M stand for ‘‘high-speed
supernatant’’ and ‘‘membrane fraction’’, respectively, corresponding
to the supernatant and the resuspended pellet recovered after ultra-
centrifugation, at 100,000 g, of the ‘‘cleared lysate’’. Arrows point out
the different target proteins and the endogenous E. coli biotinylated
protein BCCP. The membrane was probed with the Strep-Tactin HRP
conjugate (IBA).
doi:10.1371/journal.pone.0029191.g002
Figure 3. Particular cases of proteins detected in western blots
using specific antibodies. For the detection of AtHMA4 by anti-His
antibodies, AtHMA1 was also added on the blot as a positive control.
Arrows point out the different target proteins.
doi:10.1371/journal.pone.0029191.g003
Figure 4. Homologous production of AAC in A. thaliana and
presence of the recombinant protein in its original organelle,
revealed by western blot. Mitochondria were isolated and enriched,
from the leaves of 8 weeks old heterozygous Arabidopsis plants
overexpressing the protein AAC, according to two isolation methods
described by Keech et al. (lane 2) or by Brugie`re et al. (lane 4). Lanes 1 &
3 total membrane extracts before the mitochondria isolation treat-
ments. C: Strep-tag II control protein loaded at 50 ng. The arrow points
out the protein AAC. The membrane was probed with the Strep-Tactin
HRP conjugate (IBA).
doi:10.1371/journal.pone.0029191.g004
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Expression in N. benthamiana. Seven proteins were
successfully expressed in N. benthamiana (Table 3), as shown for
five of them in Figure 1E. These proteins are mainly peripheral
proteins or proteins with only one predicted TM domain. A single
protein with more than one predicted TM (UCP1 = 6 TM) was
successfully produced. ceQORH was particularly well expressed in
this system, to levels detectable on Coomassie gels (data not
shown). All but one (PHF) of the proteins detected in N. benthamiana
were also produced in A. thaliana, indicating that both hosts can be
used almost equally successfully.
During optimisation of our experimental set-up for the
overexpression of MPs in N. benthamiana, we observed that two
conditions significantly influenced the levels and/or stability of
several recombinant proteins: the growth stage of the plant, and
the light intensity in the growth chamber. The expression levels of
the recombinant MreC and ceQORH, in variations on the above-
cited growth conditions, are shown in Figure 5 as examples of the
effects of these parameters. Both MreC and ceQORH accumulate
more in older plants than in young ones. Increased accumulation
was also observed when young plants were grown under low light.
Although we did not perform any further experiments to elucidate
this phenomenon, it is possible that, since high light can induce
oxidative stress in N. benthamiana [91], this may depress protein
synthesis and/or accumulation.
Expression in Sf9 cells. As mentioned above, recombinant
bacmids were obtained for 18 genes. A first set of expression tests
was analysed by western blot on total extracts from cells infected
with these bacmids (see an example in Figure 1F). Twelve proteins
could be detected in whole-cell extracts, and their expression was
also analysed on membrane vesicles (Figure 1G). The other 6
proteins (FtsX, MraY, AtHMA4, AtHMA3, a2d subunit, and
CXCR4) were undetectable. Among the proteins expressed, AAC
showed variable results between expression experiments, and even
over time with the same sample. This suggests significant protein
instability. NapC and LPR1, although expressed were mainly
present in the unsolubilised material (see Materials and Methods);
while PHT1;4, NTT1 and CCR5 all migrated at very high
molecular weights, suggesting that they were aggregated (see
Figure 1F for PHT1;4). Some of the proteins produced in this host
were difficult to quantify for reasons including: very high
background staining on western blots with membrane vesicles
(NapC); poor transfer of aggregated protein forms (PHT1;4,
NTT1 and CCR5), and; extremely low presence in the purified
membrane fraction (LPR1). Taking all this into consideration,
eight out of 18 proteins were correctly expressed at levels ranging
from around 10–20 mg/L of culture, for AtHMA1, NapC and
MreC, to 330 mg/L, for ceQORH; Bcl-xL, PHF, UCP1 and AAC
were produced at intermediate levels (Table 3). Although these
levels are quite low compared to those produced in bacterial
cultures, as mentioned above insect cells have certain advantages
when expressing eukaryotic proteins, such as the ability to insert
post-translational modifications and disulfide bridges. Thus, in
functional tests, these cells might be a better choice.
Discussion
Gateway vectors for cloning and expression
The cloning strategy chosen for this project, based on Gateway
technology, enabled us to obtain expression vectors for the
different systems in a convenient and very efficient manner (over
99% success). Adaptation of the manufacturer’s protocol by an 8-
fold reduction of the volumes and quantities of the components
used in the BP and LR reactions also enabled us to significantly
reduce the cost of the cloning with a maintained efficiency.
However, Gateway does present some disadvantages; in particular,
the specific attB recombination sites used for cloning introduce
additional amino sequences at the N-terminus of the recombinant
proteins. Because we decided to use the same ‘‘entry’’ clones for all
the expression systems, for expression in bacterial systems, the
Ribosome Binding Site (RBS) necessary for the translation as well
as the initiation codon had to be present in the destination vector
upstream of the attR1 sequence. After the LR Gateway reaction,
the expression vector codes for a protein that contains 12 to 18
additional residues at its N-terminus (Table 2). Although short, this
additional sequence has a net charge which could interfere with
membrane insertion of the target proteins. A previous study
demonstrated that shortened att recombination sites increased the
success rate for MP expression in E. coli [72]. However, the
influence of these extensions appears to be variable, depending on
the topology of the tested proteins [92]. Indeed, in this study
expression in E. coli was highly successful using this strategy (15
proteins out of 20 detected in isolated membranes). In a previous
study, we showed that the presence or absence of these sites did
not affect the level of MP production in L. lactis [54]. However, the
presence of these additional residues could affect expression in
other bacterial hosts and perhaps explains the lower rate of success
in R. sphaeroides. In mammalian cells, adding this extra sequence at
the N-terminus of NIS protein has quite a negative effect, worse
than the absence of a Kozak consensus sequence (data not shown).
The addition of a Flag-tag epitope to the N-terminus of NIS also
hampers its expression (yields, maturation) [93]. Because of these
potential problems with protein expression, the constructs for
expression in insect cells were designed not to contain the att
sequence within the expressed protein. Among recombinatorial
cloning methods, only MAGIC [94] and In-Fusion [95] enable
seamless cloning, but these two methods require independent PCR
products for every new construct and are thus not readily
compatible with high-throughput approaches. A recent work by
Geertsma and Dutzler [20] presents an elegant new system termed
fragment exchange (FX) cloning, which enables subcloning into
multiple expression vectors and introduces only a single amino
acid to either side of the protein. FX cloning will most probably
become very popular in a near future, but for the time being, no
compatible vectors are yet commercially available and plasmids
need to be constructed and adapted to the technique. To conclude
on the cloning strategy, given the efficiency of the cloning step and
the number of ORFeome projects (and thus the huge number of
Figure 5. Effect of plant age and light intensity on the
expression of MreC and ceQORH in N. benthamiana. The N.
benthamiana plants were grown under low light (60–120 mE) or high
light (240 mE) before the infiltration with Agrobacterium. The young
plants had 4 to 6 leaves whereas the old plants started to blossom. The
membranes were then extracted and 6.8 mg of total proteins were
loaded on a gel and western-blotted. Y: young plant; O: old plant; (2):
light intensity of 60–120 mE; (+): light intensity of 240 mE. The
membrane was probed with the Strep-Tactin HRP conjugate (IBA).
doi:10.1371/journal.pone.0029191.g005
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readily available entry clones) for which Gateway technology has
been successfully exploited (for some recent examples see [24–27]),
we recommend its use when cloning a large number of target
genes in various vectors.
Strep-tag II to reveal protein expression
In this study, the 20 proteins were labelled with a Strep-tag II
sequence (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys). This tag binds
strongly to an engineered streptavidin derivative called Strep-
Tactin. It enables fast and simple one-step purification, and is
compatible with a wide range of detergents commonly used for the
solubilisation of membrane proteins [96]. Comparison of a range
of affinity tags to purify recombinant proteins from various cell
types also revealed that the Strep-tag offered the best compromise
in terms of purity and costs [97]. In our case, the tag was mainly
used for target detection in western blotting, to determine the
expression level of the proteins. The main reason why we chose
Strep-tag II over the more commonly used His6-tag is that a large
number of plant proteins contain natural polyhistidine sequences
that could lead to false positive responses with anti-His antibodies.
This would also hinder the detection of poorly expressed proteins.
In addition, commercial anti-Strep HRP-conjugates or antibodies
were available, together with protein standards for blot calibration
in all the laboratories involved in this project. Despite all these
arguments in favour of Strep-tag II, analysis of overexpressed
proteins in A. thaliana and Sf9 cells was difficult because a large
number of endogenous biotinylated proteins were present and
revealed by the Strep-Tactin conjugates used for detection in
western blots. In these systems, additional blocking steps were
required, to saturate the biotinylated proteins with avidin. In other
systems, however, these endogenous biotinylated proteins were an
advantage. For example, in E. coli, the biotinylated BCCP protein
was used to control for membrane isolation (Figure 2) while, in L.
lactis, several endogenous membrane proteins are biotinylated and
could be used as protein loading controls for western blots
(Figure 1B).
The topology of some proteins in this study is still unknown, and
could be modified when they are produced in heterologous
systems. We could not therefore predict which protein extremity
would be cytoplasmic. This was another reason to avoid using
polyhistidine tags, which can be positively charged at physiological
pHs. A positive charge is not theoretically favourable to insertion
in, or passage through, membranes. In contrast, the Strep-tag II is
neutral [92]. Despite this, all the constructs expressed in E. coli had
an N-terminal His6-tag and this had no apparent deleterious effect
given the high success rate and protein yields in this host.
However, it is possible that these yields could have been further
improved if the tag had not been included.
We do not know whether the failed detections in western blots
were due to an absence of protein expression, or to loss or
inaccessibility of the Strep-tag II. In several cases (FtsX, AtHMA3,
AtHMA4, Bcl-xL) the protein was detected using other antigenic
epitopes (anti-His or protein-specific antibodies) (Figure 3).
Therefore, it should be kept in mind that failed detection does
not necessarily indicate failed expression. To avoid this type of
problem, it is advisable to use different methods of detection, or
to modify the protein construct, for example, by moving the tag
to the other extremity, or adding extra linkers between the tag
and the protein. In another study, modified constructs of
AtHMA3 and AtHMA4 which placed the Strep-tag II at the C-
terminus were engineered for expression in L. lactis. These
proteins were detected normally using Strep-Tactin [54]. Howev-
er, in this parallel screening procedure, it was necessary to limit
the number of constructs to be tested (already 120) by making
choices, these may cause our results to appear poorer than they
are in reality.
Influence of protein properties on expression
Six expression systems, three prokaryotic (E. coli, L. lactis and R.
sphaeroides) and three eukaryotic (A. thaliana, N. benthamiana and Sf9
cells), were evaluated for their ability to overexpress a set of
20 MPs in this study. Besides their scientific importance, the
different proteins were selected to cover a broad range of protein
families, source organisms, topologies and functions. Of the
20 MPs, 17 (85%) were produced in at least one of the expression
hosts; at levels compatible with further functional and even
structural studies in some cases (70%.1 mg/L). However, as
shown in Table 3, the expression results were extremely variable.
Proteins with a large number of predicted TMs or a large MW
were generally less successful (Figure 6A). However, the trend in
individual systems sometimes differed from the global picture
(Figures S2 and S3). All the peripheral, and most IMPs containing
between one and six predicted transmembrane helices, were
successfully overexpressed. However, for IMPs with higher
numbers of TMs, the outcome was more random, and these were
often not expressed at all, which is consistent with previous studies
[98,99]. The size of the proteins is expected to affect their
expression, as smaller proteins necessarily contain fewer TMs, and
in our selection all seven proteins of less than 35 kDa contain a
maximum of six predicted TMs. These two parameters could
explain why some proteins were (or were not) expressed in all the
systems tested. For instance, ceQORH was produced in high
quantities in all systems. It is a peripheral, rather hydrophilic
protein, and, as previously demonstrated [54,100,101], only
interacts with the membrane through electrostatic interactions.
Bcl-xL, contains only one predicted TM, and was also well
expressed. On the other hand, among the proteins not expressed,
‘‘a2d subunit’’ has only one predicted TM but a molecular weight
over 120 kDa, while MraY and NIS are predicted to have 10 and
13 TMs respectively.
The organism of origin of the protein (including eukaryote
versus prokaryote) did not appear to have a significant influence
on the efficiency of expression (Figure 6B). Heterologous
expression was often successful, and homologous expression
sometimes failed, as in the cases of R. sphaeroides and A. thaliana.
When working with large and/or highly hydrophobic MPs,
none of the hosts tested really stood out, with maybe a small
exception for L. lactis, but the statistics are too small to really
conclude. With these proteins one should thus expect that
successful expression will require more effort and should focus
on optimising the expression conditions (level and time of
induction, temperature, additive in the growth medium like
glycerol or sucrose…). For example, in the work by Wagner et al.
[37] describing the E. coli strain Lemo21(DE3), the authors clearly
demonstrated that variations of growth conditions could signifi-
cantly impact on the levels of expression. In a parallel screening,
choices need to be made and the number of growth conditions
tested is limited. In this study, prior to the screen, several
conditions were tested in the different hosts, with one or more
proteins to define standard expression conditions that were finally
used for all proteins. These conditions were therefore most
probably not optimal in all cases. Then, after identification of the
most suitable expression system for one candidate protein, it may
also be required to further optimise specific expression conditions.
Mistic, a boost in E. coli expression
Overall, the best expression results in terms of success rate and
protein amounts were obtained with E. coli (protein yields .1 mg
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protein/L culture for 14 proteins). Many possible fusion tags or
proteins such as GST, MBP, NusA or Mistic [30,39] have been
described in the literature, however no system is perfect and can
solve all the problems. Mistic seems to act like a signal sequence
that targets the proteins to the inner membrane of E. coli. Its
properties and the good results obtained by others with Mistic
fusions [39,40,43,45] determined our choice to use it in this study.
In our hands too, Mistic had a positive effect and significantly
increased the yields obtained for all the 12 IMPs produced in E.
coli. In a recent report, Leviatan et al. [102] presented the use of
two hydrophilic bacterial proteins, YaiN and YbeL, for membrane
targeting of cargo proteins and compared these fusions tags with
Mistic. The yields obtained were equivalent, or even better in one
case than with Mistic, but the approach used was combinatorial,
testing 8 different constructs for each target protein to find the best
combination. This was not suitable for use here. In any case, given
the good results obtained here and elsewhere with Mistic, we
consider that the strategy applied here was more efficient and less
Figure 6. Influence of protein properties on expression. (A) Influence of the protein size and the number of TMs on the expression
success rate. The triangles represent each proteins and their colour the success with which they were expressed in the different expression systems.
Red =protein expressed in none or only one of the expression systems. Yellow=protein expressed in two or three of the expression systems.
Green=protein expressed in four to six of the expression systems. (B) Influence of the origin of proteins on the expression in the different
systems. The bars represent the percentage of positively expressed proteins in each expression host for a given category. Light blue: E. coli; Red: L.
lactis; Yellow: R. Sphaeroides; Green: A. thaliana; Dark blue: N. benthamiana, Orange: insect cells. Global expression represents the percentage of
positively expressed proteins in all expression hosts for a given category.
doi:10.1371/journal.pone.0029191.g006
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laborious. Interestingly, when Mistic was fused to the three
peripheral MPs in this study, it had a negative effect, significantly
reducing the yields of protein recovered with the plasma
membrane. This leads us to hypothesise that Mistic might not
just address the proteins to the membrane, but actually force them
into the lipid bilayer. Since peripheral proteins are quite
hydrophilic and interact with the membrane mainly through
electrostatic interactions, being forced into the hydrophobic
environment of the membrane, because of fusion to Mistic, could
thus be unfavourable.
L. lactis, an efficient and valuable alternative to E. coli
In terms of success rate and protein yields, L. lactis also gave
good results. Together with E. coli, it proved to be an adequate
system for the expression of A. thaliana MPs (Figure 6B) but, in this
case, without requiring fusion to Mistic-type tags. We believe that
this is due to the fact that both L. lactis and A. thaliana have very
similar GC-content in their genome, as well as similar amounts
and types of glycolipids in their membranes [54]. Moreover, even
produced at very low levels in L. lactis (around 0.2% of TMP),
some recombinant MPs were active in this system [54]. The
difference in protein yields obtained with the two bacteria could be
explained by the limited capacity of L. lactis to accumulate
branched-chain amino acids, thus limiting overexpression in this
host [103]. L. lactis appears to be complementary to E. coli: the
17 MPs expressed (including all the MPs from A. thaliana), could be
produced in at least one of these two bacteria. The three proteins
that failed to express in these bacteria (MraY, a2d subunit and
NIS) also failed in all the other systems tested. For the less
hydrophobic MPs, the two systems were equivalent: all the
peripheral proteins and those containing a single predicted TM
were produced in both bacteria. In contrast, MPs with higher
numbers of TMs (UCP1, AAC and PHT1;4) were only produced
in E. coli, whereas AtHMA3 and AtHMA4, as well as AtHMA1
(without the Mistic tag), were only detectable in L. lactis. Thus, L.
lactis is an efficient expression system and it should be considered
as an alternative when overexpression fails in E. coli.
The benefits of homologous and eukaryotic expression
With heterologous protein expression the recombinant protein
produced does not always truly resemble the native protein.
Conditions that produce the largest amount of protein do not
necessarily generate functional proteins [7,29,104–106] and, in
many cases, proteins are only functional after post-translational
modification, such as through glycosylation and formation of
disulfide bonds. Although several prokaryotic strains have been
developed to overcome some of these hurdles (e.g. E. coli trxB
mutants or E. coli glycosylation enabled mutants [107]), eukaryotic
systems are sometimes necessary. Three eukaryotic hosts were
selected in this project (A. thaliana, N. benthamiana, Sf9). A. thaliana
enabled homologous expression of several proteins (9 out of 20
originate from this organism) and it allowed us to show that the
protein AAC was correctly targeted to mitochondria (Figure 4).
Different approaches to protein production were used in the two
plant systems. In A. thaliana stable cell lines were generated, while
in N. Benthamiana transient agro-infiltration was used. Equivalent
yields were obtained for proteins expressed in both systems, but
more targets were produced in A. thaliana. However, the faster
turnaround time with transient agro-infiltration is a great
advantage, and facilitates screening for optimal production
conditions (e.g. light intensity). In Sf9 cells, eight proteins were
correctly overexpressed, and all five well-expressed proteins were
of eukaryotic origin. Nonetheless the rat a2d subunit and human
CXCR4 proteins were not expressed at all, and human CCR5 was
produced in an aggregated form. This suggests that insect cells are
not necessarily able to handle mammalian proteins properly.
Based on these results, and those discussed above for bacterial
protein expression, prokaryotic and eukaryotic systems are
complementary. Even though compared to E. coli, the expression
levels in the other systems are generally lower, a significant
number of targets could however be expressed, proving that L.
lactis, R. sphaeroides, A. thaliana or N. benthamiana are valuable
alternatives to more conventional expression hosts and can be
considered for expression of membrane proteins. Most of these
systems can be rather easily implemented in a laboratory. L. lactis
and R. sphaeroides systems require similar handling procedures and
instrumentations that are used for E. coli. Many commercial
alternatives are available for expression in insect cells and the
protocols are well established. However, insect cells culture
medium is three to four times more expensive than E. coli
medium. The agroinfiltration procedure required for expression in
N. benthamiana is rather simple and well described in the literature
[62,108]. Plant culturing requires an illuminated growth chamber,
but doesn’t cause major problems and a few days training in an
expert laboratory should be sufficient to learn the necessary
techniques. On the other hand, the procedures described here for
expression in A. thaliana and the obtention of stable lines requires
much more time and expertise, and one should consider a
collaboration with an appropriate laboratory.
Protein activity also needs to be evaluated to choose the
appropriate expression system for further functional studies.
Towards functional characterisation of the recombinant
proteins produced
Overexpression of membrane proteins is a challenge in itself.
Many groups aiming to characterise one of these difficult
membrane proteins, must first test the efficiency of various
expression systems before any functional characterisation can be
performed. In this study, we intentionally focused on the
expression yields of the 20 proteins tested, and on the ability of
the six different hosts to produce our target proteins. Indeed, a
good expression yield is a prerequisite for most biochemical and
biophysical experiments as it more or less determines the final
purity, concentration in solution, amount of protein available, cost
of production, etc. In addition, in some cases, producing enough
protein, whether functional or not, is a goal in itself. These
proteins can be used to develop precious tools such as, for
example, antibodies that usually work better than antibodies raised
against shorter synthetic peptides. In this study, we also chose to
study quite a diverse range of proteins (size, hydrophobicity,
origin) with different known or predicted activities, even though,
for many of them, no functional assays had yet been performed.
For most of these proteins, functional characterisation represents a
stand-alone project and it would not be possible to perform it for
the 120 host/protein combinations described here.
In parallel studies, the functionality of some of the proteins
produced during the present study has been analysed in one or
more expression hosts. Thus, ceQORH proved to be active when
produced in either E. coli or L. lactis, but its specific activity was
higher in L. lactis, and the protein could be purified without
difficulty using either the His-tag or the Strep-tag II [54]. The
activity of AAC, produced in E. coli, was also tested, it was found to
transport radioactive ATP, and was also sensitive to variations in
NaCl concentration [77]. The functionality of NTT1 in the two
bacterial systems (E. coli and L. lactis) and the influence of fusion to
Mistic fusion (in E. coli) were also analysed. This protein was active
in both in E. coli and L. lactis [54,76]. When produced in E. coli, the
protein could be purified to homogeneity and, by optimising
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growth conditions, the Mistic fusion led to a 16-fold increase in
protein yield. Although the transport activity of the fusion protein
was impaired in E. coli membranes, cleavage of the Mistic moiety
in vivo delivered a functional transporter, proving that the Mistic
strategy is a valuable approach [76]. Last but not least, of the four
plant heavy metal ATPases tested in L lactis, two were efficiently
produced and purified from this host [54]. This system was also
recently used to perform the first biochemical characterisation of a
plant copper ATPase [109].
Conclusion
This study compared several approaches for the overexpression
of a variety of recombinant membrane proteins in six expression
hosts. Our success rate was high, with 17 out of 20 proteins tested
expressed in at least one system, but large and very hydrophobic
proteins remained however hard to express whatever the host
used. It is therefore important to keep in mind that optimisation of
expression conditions can greatly improve the yields of protein
produced and it should be thoroughly undertaken after selecting
the host. If a first screen fails to identify an appropriate expression
system for a given target protein, optimisation of growth
conditions could then be attempted in one of the most successful
hosts presented here, e.g. E. coli or L. lactis.
The different systems present various advantages. Very good
yields (several mg protein/L culture) could be obtained with E. coli,
especially when Mistic fusions were used. But it is important to
gather topological information on the target before fusing it to
Mistic, as fusion with peripheral MPs was detrimental for the three
proteins tested. Therefore, Mistic should only be considered as an
aide to correct membrane targeting of IMPs. L. lactis was an
appropriate host for the expression of plant MPs, as well as a good
alternative to E. coli when expression fails in this system. We
demonstrated homologous expression in A. thaliana to be
beneficial, as it allows the investigation of subcellular targeting
(as for ACC here). The baculovirus system was less efficient than
E. coli or L. lactis, both in terms of number of expressed proteins
and quantity of protein produced, but is nonetheless a good system
(eight proteins expressed, five with a reasonable yield, out of 18
successfully cloned candidates). Moreover, insect cells appear to be
more useful for the production of functional proteins with specific
post-translational modifications, as are the other eukaryotic hosts:
A. thaliana and N. benthamiana.
In this work, we have developed a certain number of methods to
increase the throughput and rationalise the screening of MP
overexpression in both prokaryotic and eukaryotic systems. This
systematic approach was efficient since less conventional expres-
sion systems proved to be valuable alternatives and, as discussed
above, besides A. thaliana all other systems can be rather easily
implemented in other laboratories. We believe that the evaluation
of expression systems presented here is a useful starting guide for
biologists aiming to produce their favourite membrane protein in
amounts compatible with further biochemical and structural
characterisation.
Supporting Information
Figure S1 The successive cloning steps in the Gateway
technology. The Gateway Technology uses the l recombination
system to facilitate transfer of heterologous DNA sequences
(flanked by modified att sites) between vectors. BP Reaction:
Facilitates recombination of an attB-PCR product with an attP-
containing donor vector to create an attL-containing entry clone.
This reaction is catalysed by BP Clonase. LR Reaction: Facilitates
recombination of an attL-containing entry clone with an attR-
containing destination vector to create an attB-containing
expression clone. This reaction is catalysed by LR Clonase.
(TIF)
Figure S2 Influence of the number of TMs on the
expression in the different systems. The bars represent
the percentage of positively expressed proteins in each expression
host for a given category. Light blue: E. coli; Red: L. lactis; Yellow:
R. Sphaeroides; Green: A. thaliana; Dark blue: N. benthamiana,
Orange: insect cells. Global expression represents the percentage
of positively expressed proteins in all expression hosts for a given
category.
(TIF)
Figure S3 Influence of the protein size on the expression
in the different systems. The bars represent the percentage of
positively expressed proteins in each expression host for a given
category. Light blue: E. coli; Red: L. lactis; Yellow: R. Sphaeroides;
Green: A. thaliana; Dark blue: N. benthamiana, Orange: insect cells.
Global expression represents the percentage of positively expressed
proteins in all expression hosts for a given category.
(TIF)
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